PRAXIS PRECISION MEDICINES, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $88.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-19
- PRAXIS PRECISION MEDICINES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $88.30M, a 133.60% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $37.80M, a 3.28% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $36.60M, a 36.90% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $58.00M, a 18.13% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $88.30M 10-K · filed 2026-02-19 |
| 2024-12-31 | $37.80M 10-K · filed 2026-02-19 |
| 2023-12-31 | $36.60M 10-K · filed 2025-02-28 |
| 2022-12-31 | $58.00M 10-K · filed 2024-03-05 |
| 2021-12-31 | $49.10M 10-K · filed 2023-02-07 |
| 2020-12-31 | $17.30M 10-K · filed 2022-02-28 |
| 2019-12-31 | $10.50M 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |